65th ASH Annual Meeting and Exposition - December 09-12, 2023
Venue: San Diego Convention Center 111 W Harbor Drive San Diego, CA 92101
Oncoletter hat für Sie in Kooperation mit INFO@ONCO-SUISSE die Abstracts aus den klinisch orientierten Oral Sessions übersetzt und zusammengefasst. Damit bieten die Texte leicht lesbar einen schnellen Überblick zu den wichtigsten Studien, die am ASH mündlich vorgestellt werden. Mittels eines Links kann jede Studie im Originalabstract nachgelesen werden.
Lymphome: Kommentar Prof. Christoph Renner, Zürich
Das Laden von Vimeo wurde nicht erlaubt. Bitte ändern Sie die Datenschutz-Einstellungen
Myelome: Kommentar Prof. Christoph Renner, Zürich
Das Laden von Vimeo wurde nicht erlaubt. Bitte ändern Sie die Datenschutz-Einstellungen
- ASH Press Briefings on Late Breaking and other important Abstracts
- Late-Breaking Abstracts Session
-
Acute Lymphoblastic Leukemias
- ALL: Clinical and Epidemiological studies
-
ALL: Therapies, Excluding Transplantation and Cellular Immunotherapies
- Therapies, Excluding Transplantation and Cellular Immunotherapies: Optimal Frontline Treatment for ALL - Monday, December 11, 2023: 2:45 PM-4:15 PM Grand Hall C (Manchester Grand Hyatt San Diego)
- Therapies, Excluding Transplantation and Cellular Immunotherapies: Novel Therapies for ALL - Monday, December 11, 2023: 4:30 PM-6:00 PM Grand Hall D (Manchester Grand Hyatt San Diego)
-
Acute Myeloid Leukemias
-
AML: Clinical and Epidemiological studies
- Clinical and Epidemiological: Real World Outcomes and Treatment Approaches - Sunday, December 10, 2023: 4:30 PM-6:00 PM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
- Clinical and Epidemiological: Innovations in Prognostication - Monday, December 11, 2023: 10:30 AM-12:00 PM Room 6B (San Diego Convention Center)
- Clinical and Epidemiological: AML: De Novo and Myelodysplasia-Related - Monday, December 11, 2023: 2:45 PM-4:15 PM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
- Clinical and Epidemiological: AML Molecular Targets, Ethnicity, and AI - Monday, December 11, 2023: 4:30 PM-6:00 PM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
-
AML: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies
- Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Long-Term Outcomes for Children and Adults Diagnosed With AML/APL - Monday, December 11, 2023: 10:30 AM-12:00 PM Room 6A (San Diego Convention Center)
- Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Refining Chemotherapy Regimens Plus/Minus MRD Evaluation to Optimize Outcomes in AML - Mon, Dec11, 23: 2:45PM-4:15PM San Diego Ballroom AB Marriott Marquis SD Marina
- Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Improving Intensive Chemotherapy Regimens for Treatment of AML - Mon, Dec 11, 2023: 4:30PM-6:00PM San Diego Ballroom AB (Marriott Marquis San Diego Marina)
-
AML: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies
- Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Upcoming Therapies in Newly Diagnosed and Relapsed/Refractory AML - Sat, Dec 9, 2023: 9:30 AM-11:00 AM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego M
- Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Novel Uses of Approved Therapeutic Agents - Saturday, December 9, 2023: 2:00 PM-3:30 PM Room 6A (San Diego Convention Center)
-
AML: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis
- Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Risk Refinement and Therapy Response - Saturday, December 9, 2023: 9:30 AM-11:00 AM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
- Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Biomarkers and Therapeutics - Saturday, December 9, 2023: 2:00 PM-3:30 PM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
- Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Minimal Residual Disease and Therapy Response - Sunday, December 10, 2023: 9:30 AM-11:00 AM Marriott Grand Ballroom 8-9 (Marriott Marquis San Diego Marina)
- Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Immunologic and Metabolic Biomarkers of Disease Control - Saturday, December 9, 2023: 4:00 PM-5:30 PM Room 6CF (San Diego Convention Center)
- Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Deciphering Risk by Genetic and Epigenetic Features - Mon, Dec 11, 2023: 2:45 PM-4:15 PM Pacific Ballroom Salons 15-17 Marriott Marquis San Diego Marina
- Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Response Predictors to Targeted Therapies and Transplant - Mon, Dec 11, 2023: 4:30 PM-6:00 PM Pacific Ballroom Salons 15-17 (Marriott Marquis San Diego Marina)
-
AML: Clinical and Epidemiological studies
-
Chronic Myeloid Leukemia
-
CML: Clinical and Epidemiological studies
- CML: Clinical and Epidemiological: Treatment-Free Remission and Prognostication - Sunday, December 10, 2023: 9:30 AM-11:00 AM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
- CML: Clinical and Epidemiological: Novel Therapeutic Approaches - Monday, December 11, 2023: 2:45 PM-4:15 PM Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
-
CML: Clinical and Epidemiological studies
-
Myeloproliferative Syndromes and Chronic Myeloid Leukemia
-
MPS and CML: Basic and Translational
- MPS and CML: Basic and Translational: Lineage Tracing and Novel Target Discovery - Monday, December 11, 2023: 2:45 PM-4:15 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
- MPS and CML: Basic and Translational: Oncogenic Drivers and Genetic Models - Monday, December 11, 2023: 4:30 PM-6:00 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
- MPS and CML: Basic and Translational: Oncogenic Drivers and Genetic Models - Monday, December 11, 2023: 4:30 PM-6:00 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
-
MPS: Clinical and Epidemiological
- MPS: Clinical and Epidemiological: Rare Myeloproliferative Neoplasms: Unveiling Promising Pathways and Novel Therapies - Saturday, December 9, 2023: 9:30 AM-11:00 AM Ballroom 20AB (San Diego Convention Center)
- MPS: Clinical and Epidemiological: Charting The Future Of MPN Therapies - Sunday, December 10, 2023: 4:30 PM-6:00 PM Ballroom 20CD (San Diego Convention Center)
- MPS: Clinical and Epidemiological: Myelofibrosis: New Therapeutic Frontiers - Sunday, December 10, 2023: 4:30 PM-6:00 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
- MPS: Clinical and Epidemiological: Treatment and Outcomes in MPNs - Monday, December 11, 2023: 10:30 AM-12:00 PM Ballroom 20CD (San Diego Convention Center)
-
MPS and CML: Basic and Translational
-
Lymphomas
-
Lymphomas: Translational
- Lymphomas: Translational – Molecular and Genetic: Microenvironment and Methylome in Lymphoma and Misc - Saturday, December 9, 2023: 2:00 PM-3:30 PM Ballroom 20AB (San Diego Convention Center)
- Lymphomas: Translational – Molecular and Genetic: Signaling Pathways and MRD in Lymphoma - Sunday, December 10, 2023: 12:00 PM-1:30 PM Harbor Ballroom (Manchester Grand Hyatt San Diego)
- Lymphomas: Translational – Molecular and Genetic: Insights into Lymphoma: Unraveling the Molecular Complexity for Precision Diagnostics and Therapeutics - Monday, December 11, 2023: 2:45 PM-4:15 PM Room 6DE (San Diego Convention Center)
- Lymphomas: Translational – Non-Genetic: Illuminating the Tumor Microenvironment and Immune Landscape in Lymphoma - Saturday, December 9, 2023: 2:00 PM-3:30 PM Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
- Lymphomas: Translational – Non-Genetic: Elucidating Biomarkers and Mechanisms of Therapy in Lymphoma - Sunday, December 10, 2023: 9:30 AM-11:00 AM Grand Hall C (Manchester Grand Hyatt San Diego)
-
Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas
- Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Immunotherapy - Sunday, December 10, 2023: 4:30 PM-6:00 PM Grand Hall C (Manchester Grand Hyatt San Diego)
- Mantle Cell, Follicular and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Prospective Clinical Trials in Mantle Cell Lymphoma Incorporating Novel Agents - Monday, December 11: 10:30 AM-12 PM Grand Hall B (Manchester Grand Hyatt S
- Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Targeted Therapy - Monday, December 11, 2023: 4:30 PM-6:00 PM Grand Hall C (Manchester Grand Hyatt San Diego)
-
Hodgkin Lymphomas and T/NK cell Lymphomas
- Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Topics in T Cell, Szary and Hodgkin Lymphomas - Saturday, December 9, 2023: 2:00 PM-3:30 PM Grand Hall B (Manchester Grand Hyatt San Diego)
- Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Advances in Treating T Cell Lymphomas - Saturday, December 9, 2023: 4:00 PM-5:30 PM Grand Hall B (Manchester Grand Hyatt San Diego)
- Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Advances in the Treatment of Hodgkin Lymphoma - Sunday, December 10, 2023: 4:30 PM-6:00 PM Grand Hall B (Manchester Grand Hyatt San Diego)
-
Aggressive Lymphomas
- Aggressive Lymphomas: Prospective Therapeutic Trials: Novel Therapies For Relapsed/Refractory Aggressive Lymphoma - Sunday, December 10, 2023: 9:30 AM-11:00 AM Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
- Aggressive Lymphomas: Prospective Therapeutic Trials: Initial treatment strategies in aggressive B Cell lymphomas - Monday, December 11, 2023: 2:45 PM-4:15 PM Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
- Aggressive Lymphomas: Clinical and Epidemiological: Real World Data on Outcomes and Treatment-Related Toxicity in B Cell NHL - Saturday, December 9, 2023: 9:30 AM-11:00 AM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
- Aggressive Lymphomas: Clinical and Epidemiological: Diagnostic and Prognostic Implications in the Care of Patients With Aggressive Lymphomas - Saturday, December 9, 2023: 2:00 PM-3:30 PM Grand Hall C (Manchester Grand Hyatt San Diego)
- Aggressive Lymphomas: Clinical and Epidemiological: Outcomes of Relapsed/Refractory DLBCL Treated with Immunochemotherapy, CAR-T Cell and Novel Agents - Saturday, December 9, 2023: 4:00 PM-5:30 PM Grand Hall C (Manchester Grand Hyatt San Diego)
- Aggressive Lymphomas: Clinical and Epidemiological: Treatment to Best Outcomes: Find the Right Therapy for the Right Patient - Sunday, December 10, 2023: 9:30 AM-11:00 AM Grand Hall D (Manchester Grand Hyatt San Diego)
- Aggressive Lymphomas: Clinical and Epidemiological: Aiming for the Right Target: Using CAR-T and Bispecifics in Aggressive Lymphomas - Sunday, December 10, 2023: 4:30 PM-6:00 PM Ballroom 20AB (San Diego Convention Center)
- Aggressive Lymphomas: Clinical and Epidemiological: Uncommon Aggressive NHL - Monday, December 11, 2023: 4:30 PM-6:00 PM Harbor Ballroom (Manchester Grand Hyatt San Diego)
-
Lymphomas: Translational
-
Chronic Lymphocytic Leukemias
-
CLL
- Chronic Lymphocytic Leukemias: Basic and Translational: Molecular Determinants of CLL and Richter Transformation - Saturday, December 9, 2023: 9:30 AM-11:00 AM Grand Hall B (Manchester Grand Hyatt San Diego)
- Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Analysis and Treatment of High Risk and Treatment of Relapsed CLL or Richter Transformation - Saturday, December 9, 2023: 2:00 PM-3:30 PM Grand Hall D (Manchester Grand Hyatt San Diego)
- Chronic Lymphocytic Leukemia: Clinical and Epidemiological: New Inhibitors and Cellular Therapies for Treatment of Relapsed CLL - Saturday, December 9, 2023: 4:00 PM-5:30 PM Grand Hall D (Manchester Grand Hyatt San Diego)
- Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Frontline Treatment With Targeted Agents in Patients With Chronic Lymphocytic Leukemia - Sunday, December 10, 2023: 4:30 PM-6:00 PM Seaport Ballroom ABCD (Manchester Grand Hyatt)
-
CLL
-
Myelodysplastic Syndromes
-
MDS
- Myelodysplastic Syndromes – Basic and Translational: Molecular Drivers and Therapeutic Implications - Saturday, December 9, 2023: 4:00 PM-5:30 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
- Myelodysplastic Syndromes – Clinical and Epidemiological: Treatment Options and Decision Making in Low Risk MDS - Saturday, December 9, 2023: 2:00 PM-3:30 PM Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
- Myelodysplastic Syndromes – Clinical and Epidemiological: Treatments and Outcome Predictions in High Risk MDS - Saturday, December 9, 2023: 4:00 PM-5:30 PM Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
- Myelodysplastic Syndromes – Clinical and Epidemiological: Genomic Classification and Prognostication of MDS - Monday, December 11, 2023: 4:30 PM-6:00 PM Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
-
MDS
-
Multiple Myeloma and Plasma Cell Dyscrasias
-
Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational
- Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Spatial Dissection and Multiomics Analysis of the Multiple Myeloma Tumor and Immune Microenvironment - Saturday, Dec 9: 9:30 AM-11AM Harbor Ballroom (Manchester Grand Hya
- Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Characterization of the MM and the Tumor Microenvironment - Saturday, December 9, 2023: 4:00 PM-5:30 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
- Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Characterizing Response and Resistance to CAR-T and TCEs - Sunday, December 10, 2023: 9:30 AM-11:00 AM Harbor Ballroom (Manchester Grand Hyatt San Diego)
- Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Molecular Characterization of MM and Precursor Disease States - Sunday, December 10, 2023: 4:30 PM-6:00 PM Harbor Ballroom (Manchester Grand Hyatt San Diego)
- Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Advancing Therapies in Multiple Myeloma and Waldenström's Macroglobulinemia - Monday, December 11, 2023: 10:30 AM-12:00 PM Harbor Ballroom (Manchester Grand Hyatt San Diego)
- Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Multiple Myleoma Circulating Tumor Cells, Novel Mechanisms, and Immune Interactions - Monday, December 11, 2023: 2:45 PM-4:15 PM Harbor Ballroom (Manchester Grand Hyatt)
-
Multiple Myeloma: Clinical and Epidemiological
- Multiple Myeloma: Clinical and Epidemiological: T Cell Redirecting Therapy Outcomes and Associated Complications - Saturday, December 9, 2023: 9:30 AM-11:00 AM Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
- Multiple Myeloma: Clinical and Epidemiological: Minimal Residual Disease and Alternative Non-Invasive Bio Marker Evaluations in Myeloma Therapeutics - Saturday, December 9, 2023: 4:00 PM-5:30 PM Harbor Ballroom (Manchester Grand Hyatt San Diego)
- Multiple Myeloma: Clinical and Epidemiological: Monoclonal Gammopathies of Determined Significance - Novel Insights on the Relevance of Gammopathies and Misc - Sun, Dec 10: 12 PM-1:30 PM Grand Hall C (Manchester Grand Hyatt San Diego)
- Multiple Myeloma: Clinical and Epidemiological: Novel Biomarkers for Treatment Guidance in Multiple Myeloma - Sunday, December 10, 2023: 4:30 PM-6:00 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
- Multiple Myeloma: Clinical and Epidemiological: Immunological Effects of Sustained Responses in Multiple Myeloma - Monday, December 11, 2023: 10:30 AM-12:00 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
- Multiple Myeloma: Clinical and Epidemiological: Molecular and Biological Signatures and Predictors of Outcomes - Monday, December 11, 2023: 2:45 PM-4:15 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
- Multiple Myeloma: Clinical and Epidemiological: Predicting Outcome and Side Effects of Novel Immunotherapies in Multiple Myeloma - Monday, December 11, 2023: 4:30 PM-6:00 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
-
Multiple Myeloma: Prospective Therapeutic Trials
- Multiple Myeloma: Prospective Therapeutic Trials: Smoldering and Newly Diagnosed Myeloma - Saturday, December 9, 2023: 2:00 PM-3:30 PM Harbor Ballroom (Manchester Grand Hyatt San Diego)
- Multiple Myeloma: Prospective Therapeutic Trials: Relapsed and Refractory Myeloma - Monday, December 11, 2023: 4:30 PM-6:00 PM Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
-
MGUS, Amyloidosis and Other Non-Myeloma Plasma Cell Dyscrasias
- MGUS, Amyloidosis & Other Non-Myeloma Plasma Cell Dyscrasias: Clinical & Epidemiological: Screening to Vaccines Spectrum of Plasma Cell Disorders - Sat, Dec 9: 2 PM-3:30 PM Seaport Ballroom EFGH (Manchester Grand Hyatt)
- MGUS, Amyloidosis & Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: From Light Chain to Fibril–Novel Diagnostics to Treatments for Amyloidosis - Sun, Dec 10: 12 PM-1:30 PM Seaport Ballroom EFGH (Manchester Grand
-
Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational
-
Cellular Immunotherapies
-
Cellular Immunotherapies: Late Phase and Commercially Available Therapies
- Cellular Therapy for B Cell Lymphomas: Prospective Clinical Trials and Real World Data - Saturday, December 9, 2023: 9:30 AM-11:00 AM Room 6A (San Diego Convention Center)
- Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Translational Data and Prognostic Factors - Saturday, December 9, 2023: 2:00 PM-3:30 PM Room 6CF (San Diego Convention Center)
- Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Prediction and Management of CAR-T Cell Related Toxicity - Saturday, December 9, 2023: 4:00 PM-5:30 PM Room 6B (San Diego Convention Center)
- Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Cellular Therapy for Multiple Myeloma, B-cell Acute Lymphoblastic Leukemia and B Cell Lymphomas: Clinical Trial and Real World Evidence - Monday, December 11, 2023: 4:30 PM-6:00 PM
-
Cellular Immunotherapies: Late Phase and Commercially Available Therapies